Your session is about to expire
← Back to Search
Parent-Mediated Intervention for Autism Spectrum Disorder (PRIMeR Trial)
N/A
Recruiting
Led By Isabel M Smith, PhD
Research Sponsored by IWK Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, entry to ei program, and after 6 months of ei program
Awards & highlights
No Placebo-Only Group
Summary
This trial tests two therapies for young children with autism who haven't responded well to usual treatments. The therapies involve parents playing with their children to encourage communication and social skills. One therapy focuses on general improvement, while the other targets specific weaknesses.
Who is the study for?
This trial is for preschoolers with autism spectrum disorder in Nova Scotia who show minimal response to standard treatments. They should have limited positive emotions, use fewer than 10 words spontaneously, and be about to enroll in the NS EI program. Children with severe sensory or motor impairments or whose parents can't consent in English are excluded.
What is being tested?
The study tests a brief parent-led intervention called PRIMeR aimed at increasing children's responsiveness to Pivotal Response Treatment (PRT), an existing method used by the publicly funded autism early intervention program in Nova Scotia.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medication, traditional side effects are not expected. However, there may be variations in individual responses to therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at baseline, entry to ei program, and after 6 months of ei program
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, entry to ei program, and after 6 months of ei program
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Social initiations
Secondary study objectives
Communication
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PRIMeRExperimental Treatment1 Intervention
Virtual parent coaching in use of a novel intervention consisting of Social Routines and Reciprocal Imitation Training strategies
Group II: PRTActive Control1 Intervention
Virtual parent coaching in use of Pivotal Response Treatment strategies
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Autism Spectrum Disorder (ASD) often involve behavioral and educational interventions such as Applied Behavior Analysis (ABA) and naturalistic developmental behavioral interventions (NDBIs) like Pivotal Response Treatment (PRT). These methods work by reinforcing desired behaviors and improving social communication and adaptive skills through structured and naturalistic settings.
Parent-mediated interventions, where caregivers are trained to apply these strategies, are particularly effective as they provide consistent reinforcement in the child's daily environment. Understanding these mechanisms is crucial for ASD patients as it allows for personalized interventions that can significantly enhance developmental outcomes and quality of life.
Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials.Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.
Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials.Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.
Find a Location
Who is running the clinical trial?
IWK Health CentreLead Sponsor
129 Previous Clinical Trials
112,088 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
883 Patients Enrolled for Autism Spectrum Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,527,426 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
548 Patients Enrolled for Autism Spectrum Disorder
Isabel M Smith, PhDPrincipal InvestigatorIWK Health Centre and Dalhousie University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child uses toys or objects less than expected.I cannot complete the consent process or receive coaching in English.My child has severe difficulties in feeling or moving.My child is about to join an early intervention program for autism.
Research Study Groups:
This trial has the following groups:- Group 1: PRIMeR
- Group 2: PRT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.